Claire Dyer is a director of submissions and medical writer with experience in multidisciplinary clinical, academic, and corporate environments. She has 20 years of experience in clinical development, including 15 years in medical writing and experience with global marketing applications for both biologics and small molecules, as well as for Investigational New Drug (IND) and Clinical Trial Authorisation (CTA) applications. Claire has led submission teams, including project management, writing submission level documents as well as training and mentoring of junior writers. Her interest in the field of oncology has continued since her PhD in adoptive T cell therapy for lymphoma.
Claire Dyer Director of Submissions and Medical Writer